NCT00445965 2024-04-04
Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
Memorial Sloan Kettering Cancer Center
Canadian Cancer Trials Group
Abramson Cancer Center at Penn Medicine
University of California, San Francisco
National Cancer Institute (NCI)
University of California, Davis